Axial Therapeutics announced it is expanding the age eligibility criterion to include children ages 5 to 17 years in...
Read more
Axial Therapeutics announced key promotions in its research and development organization. These promotions recognize the Axial team’s scientific and...
Read more
MemVerge attends MemCon to demonstrate the capacity and performance benefits of Compute Express Link™ (CXL™) memory. The demo features a...
Read more
TechArena host Allyson Klein chats with MemVerge founder and CEO Charles Fan about his company’s disruptive vision for breaking...
Read more
“The reason they target that time to sell is because [trials] are expensive, but relatively inexpensive [compared to the...
Read more
PteroDynamics announced the appointment of Richard Brasel as its Chief Revenue Officer. Brasel brings with him a wealth of...
Read more
PteroDynamics announced the close of a $7.5 million Seed round. The round was co-led by existing investor Kairos Ventures...
Read more
Tempus announced a brand-new multi-omics collaboration with Actuate Therapeutics to support its ongoing Phase 1/2 Study of elraglusib, formerly...
Read more
At the turn of the 21st century, scientists Robert Langreth and Michael Waldholz posited a new idea: What if...
Read more
Becky Schultz speaks with founder and CEO of Transient Plasma Systems, Dan Singleton, about the company’s plasma-based aftertreatment and...
Read more